Brazil in the research and development of vaccines: innovation policies and measurable results
by Cássia Rita Pereira Da Veiga; Claudimar Pereira Da Veiga; Jansen Maia Del Corso; Wesley Vieira Da Silva
International Journal of Business Innovation and Research (IJBIR), Vol. 15, No. 2, 2018

Abstract: This paper investigates the Brazilian innovation policy to encourage research and development (R&D) of NTDs vaccines and evaluates the measurable results achieved by Brazil from the perspective of intellectual property over the past 35 years. It is possible to note the significant national efforts that have been made in Brazil to ensure that national policies and technological and industrial strategies incorporate innovation in NTDs vaccines. Regarding patent date, Brazil can be analysed as an innovative developing country and the R&D of vaccines for NTDs has progressed slowly over the past 35 years. Moreover, Brazilian R&D remains under the responsibility of public institutions and the establishment of public-private partnerships is still limited. On the other hand, this study highlights an important change in NTDs scenario, with increased participation of private companies. Finally, this study establishes a criticism in confronting the incentives of Brazilian innovation policy with the findings of empirical research.

Online publication date: Mon, 08-Jan-2018

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Innovation and Research (IJBIR):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com